The number of generics per a bioequivalence test was 4 products… the number of the tests went also up

As the regulation to restrict the number of companies participating in a joint or consigned bioequivalence test to 2 companies was abolished, the number of consigned bioequivalence tests increased.

As the result of aggregating the total number of products approved in bioequivalence tests between 2009 and 2013, less than or equalto 2 generics were launched per a single equivalence test by 2011,...